Cardinal Health Omeprazole Delayed Release Tablets 20 mg Drug Facts | leader omeprazole
Omeprazole delayed-release tablet, 20 mg
Acid reducer
Allergy alert: Do not use if you are allergic to omeprazole
if you have trouble or pain swallowing food, vomiting with blood, or bloody or black stools. These may be signs of a serious condition. See your doctor.
taking
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)
14-Day Course of Treatment
Repeated 14-Day Courses (if needed)
carnauba wax, ferric oxide red, ferric oxide yellow, hypromellose, hypromellose acetate succinate, lactose monohydrate, monoethanolamine, propylene glycol, sodium lauryl sulfate, sodium starch glycolate, sodium stearate, sodium stearyl fumarate, talc, titanium dioxide, triethyl citrate
1-800-719-9260
Omeprazole Delayed Release Tablets 20 mg
Acid Reducer
Please read all of this package insert before taking Omeprazole Delayed Release Tablets 20 mg.
Save this to read, as you need.
How Omeprazole Delayed Release Tablets 20 mg Work For Your Frequent Heartburn
Omeprazole Delayed Release Tablets 20 mg work differently from other heartburn products, such as antacids and other acid reducers. Omeprazole Delayed Release Tablets 20 mg stop acid production at the source - the acid pump that produces stomach acid. Omeprazole Delayed Release Tablets 20 mg are to be used once a day (every 24 hours), every day for 14 days.
What to Expect When Using Omeprazole Delayed Release Tablets 20 mg
Omeprazole Delayed Release Tablets 20 mg are a different type of medicine from antacids and other acid reducers. Omeprazole Delayed Release Tablets 20 mg may take 1 to 4 days for full effect, although some people get complete relief of symptoms within 24 hours. Make sure you take the entire 14 days of dosing to treat your frequent heartburn.
Who Should Take Omeprazole Delayed Release Tablets 20 mg
This product is for adults (18 years and older) with frequent heartburn-when you have heartburn 2 or more days a week.
■ Children under 18 years of age: ask a doctor. Heartburn in children may sometimes be caused by a serious condition.
■ Omeprazole Delayed Release Tablets 20 mg are not intended for those who have heartburn infrequently, one episode of heartburn a week or less, or for those who want immediate relief of heartburn.
How to Take Omeprazole Delayed Release Tablets 20 mg
14-Day Course of Treatment
■ Swallow 1 tablet with a glass of water before eating in the morning.
■ Take every day for 14 days.
■ Do not take more than 1 tablet a day.
■ Do not chew or crush the tablets.
■ Do not crush tablets in food.
■ Do not use for more than 14 days unless directed by your doctor.
It is important not to chew or crush these tablets, or crush the tablets in food. This decreases how well Omeprazole Delayed Release Tablets 20 mg work.
When to Take Omeprazole Delayed Release Tablets 20 mg Again
You may repeat a 14-day course of therapy every 4 months.
When to Talk to Your Doctor
Do not take for more than 14 days or more often than every 4 months unless directed by a doctor.
Warnings and When to ask Your Doctor
Allergy alert: Do not use if you are allergic to omeprazole
Do not use if you have trouble or pain swallowing food, vomiting with blood, or bloody or black stools. These may be signs of a serious condition. See your doctor.
Ask a doctor before use if you have
■ had heartburn over 3 months. This may be a sign of a more serious condition.
■ heartburn with lightheadedness, sweating or dizziness
■ chest pain or shoulder pain with shortness of breath; sweating; pain spreading to arms, neck or shoulders; or lightheadedness
■ frequent chest pain
■ frequent wheezing, particularly with heartburn
■ unexplained weight loss
■ nausea or vomiting
■ stomach pain
Ask a doctor or pharmacist before use if you are taking
■ warfarin, clopidogrel or cilostazol (blood-thinning medicines)
■ prescription antifungal or anti-yeast medicines
■ diazepam (anxiety medicine)
■ digoxin (heart medicine)
■ tacrolimus (immune system medicine)
■ prescription antiretrovirals (medicines for HIV infection)
Stop use and ask a doctor if
■ your heartburn continues or worsens
■ you need to take this product for more than 14 days
■ you need to take more than 1 course of treatment every 4 months
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)
Tips for Managing Heartburn
■ Do not lie flat or bend over soon after eating.
■ Do not eat late at night or just before bedtime.
■ Certain foods or drinks are more likely to cause heartburn, such as rich, spicy, fatty and fried foods, chocolate, caffeine, alcohol and even some fruits and vegetables.
■ Eat slowly and do not eat big meals.
■ If you are overweight, lose weight.
■ If you smoke, quit smoking.
■ Raise the head of your bed.
■ Wear loose-fitting clothing around your stomach.
How are Omeprazole Delayed Release Tablets 20 mg Sold
Omeprazole Delayed Release Tablets 20 mg are available in 14 tablet, 28 tablet and 42 tablet sizes. These sizes contain one, two and three 14-day courses of treatment, respectively. Do not use for more than 14 days in a row unless directed by your doctor. For the 28 count (two 14-day courses) and the 42 count (three 14-day courses), you may repeat a 14-day course every 4 months.
For Questions or Comments About Omeprazole Delayed Release Tablets 20 mg
Call 1-800-719-9260
Made in Israel
DISTRIBUTED BY
PERRIGO®
ALLEGAN, MI 49010
Manufactured by:
Dexcel Pharma
Technologies Ltd.
10 Hakidma Street,
Yokneam, 20692, Israel
Treats Frequent Heartburn!
Occurring 2 or More Days a Week
Omeprazole Delayed Release Tablets 20 mg
Acid Reducer
# 14-day course{s} of treatment {Replace “#” with the number of courses of treatment in the package}
Actual Size


Manufacturer
Active Ingredients
Source
- U.S. National Library of Medicine
- DailyMed
- Last Updated: 4 May 2013
Drugs and Medications
Leader 44-137
Leader 44-194
Cromolyn sodium [Cardinal Health]
Cromolyn Sodium Nasal Solution USPNASAL SPRAY
Extra strength pain reliever [CARDINAL HEALTH]
Leader 44-519
Omeprazole [Dexcel Pharma Technologies Ltd.]
Omeprazole Delayed Release Tablets, 20 mg
Clinical Trials
Pharmacokinetics of Immediate-Release vs. Delayed-Release Omeprazole in Gastroparesis
The purpose of this study is to compare the blood drug levels of two prescribed medications, immediate-release omeprazole 40 mg powder and delayed-release omeprazole 40 mg capsule to deter...
Drug Interaction Study With Proton Pump Inhibitor
The purpose of this clinical research study is to assess the effect of omeprazole at 20 mg on the pharmacokinetics of atazanavir administered as atazanavir with ritonavir relative to ataza...
Sopran - Omeprazole Treatment Versus Surgery
The purpose of this study is to study gastritis, GI symptoms during long term omeprazole treatment
Evaluation of Omeprazole Effect on Glaucoma
Omeprazole is a safe drug listed in OTC drug due to its safety. It acts by irreversible inhibition of K/H ATP ase pump and also Na/K ATP ase, Na/H ATP ase.Considering these actions the ef...
Bioequivalence Study of Omeprazole Magnesium 20 mg DR Capsule Under Fed Conditions
An open label, balanced, randomized, two-treatment, two-period, two-sequence, single dose, crossover oral bioequivalence study of Omeprazole Magnesium 20 mg DR capsules of Dr. Reddy's Labo...
PubMed Articles
Efavirenz-mediated induction of omeprazole metabolism is CYP2C19 genotype dependent.
Efavirenz increases CYP2C19- and CYP3A-mediated omeprazole metabolism. We hypothesized that CYP2C19 and CYP2B6 genetic polymorphisms influence the extent of induction of omeprazole metabolism by efavi...
PURPOSE: To elucidate the stereoselective pharmacokinetics of omeprazole enantiomers and their metabolites after racemic IV dosing because there is little information about the stereoselective metabol...
The aim of this open-label, randomized, and 3-period crossover study was to evaluate the influences of concomitant antacid administration on the plasma disposition, intestinal absorption, and urinary...
Background: Emerging data suggests that several proton pump inhibitors (PPIs), including omeprazole, might interfere with the antiplatelet action of clopidogrel. However, there is a lack of data for r...
PURPOSE: To develop a limited sampling strategy (LSS) to predict area under the concentration-time curve (AUC) ratios of omeprazole (AUC(OPZ)) to its metabolites 5-hydroxyomepraz...